Table 1 Characteristics of cohort studies included in the meta-analysis

From: Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

Study

Country

No. of cases (men/women)

Study participants

Assessment of exposure

Adjustments

Møller et al (1994)

Denmark

22/36

Men: 14 531

Women: 29 434

Discharge diagnosis of obesity

Age

Wolk et al (2001)

Sweden

15/13

Men: 8165

Women: 19 964

Discharge diagnosis of obesity

Age, calendar year

Nair et al (2002)

USA

659a

Men and women: 19 271a

Measured

Age, sex, race, diabetes

Calle et al (2003)

USA

620/345

Men: 404 576

Women: 495 477

Self-reported

Age, race, education, marital status, smoking, physical activity, aspirin use, estrogen-replacement therapy (women), alcohol, dietary factors

Samanic et al (2004)

USA

322 whites/38 blacks

White men: 3 668 486

Black men: 832 214

Discharge diagnosis of obesity

Age, calendar year

Kuriyama et al (2005)

Japan

69/31

Men: 12 485

Women: 15 054

Self-reported

Age, type of health insurance, smoking, intakes of alcohol, meat, fish, fruits, vegetables, bean-paste soupb

Batty et al (2005)

UK

51

Men: 18 403

Measured

Age, employment grade, marital status, physical activity, smoking, otherc

Oh et al (2005)

Korea

3347

Men: 781 283

Measured

Age, area of residence, family history of cancer, smoking, exercise, alcohol

Rapp et al (2005)

Austria

57

Men: 67 447

Measured

Age, occupational group, smoking

N'Kontchou et al (2006)

France

220a

Men and women: 771a

Measured

Age, sex, cirrhosis cause, diabetes

Samanic et al (2006)

Sweden

297

Men: 362 552

Measured

Age, smoking

  1. aPatients with cirrhosis.
  2. bOdds ratios for women were further adjusted for age at menarche, age at end of first pregnancy, and menopausal status.
  3. cOther factors adjusted for include disease at entry, weight loss in the last year, height-adjusted FEV1, triceps skinfold thickness, blood pressure-lowering medication, blood pressure, plasma cholesterol, glucose intolerance, and diabetes.